Mathur, Anandita
Ozkaya, Efe
Rosberger, Sonam
Sigel, Keith M.
Doucette, John T.
Bansal, Meena B.
Taouli, Bachir https://orcid.org/0000-0001-6409-1333
Article History
Received: 20 November 2024
Revised: 31 January 2025
Accepted: 21 February 2025
First Online: 30 March 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Dr. Bachir Taouli.
: A.M., E.O., S.R., K.M.S, and J.T.D. have no conflicts of interest to declare. M.B.B. has received funding for research from Pfizer, The Kinetix Group, Histoindex, and Siemens. M.B.B. provides consulting services for The Kinetix Group, Madrigal, Pfizer, Fibronostics, NOVO Nordisk, GSK, Boston Pharma, Merck, and Boehringer-Ingelheim. B.T. receives funding for research from Bayer, Takeda, Regeneron, Helio Health, Echosens, Guerbet, and Siemens. Additionally, B.T. provides consulting services for Bayer, Guerbet, and Ascelia.
: One of the authors, John T Doucette, has significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Study subjects or cohorts have not been previously reported.
: